China v USA

Here Are Two ETFs Offering Exposure To Biotech In China

Here Are Two ETFs Offering Exposure To Biotech In China

According to Loncar Funds, biotechnology innovation matters. Whether it is a cure for hepatitis C, new advances in cancer care, or progress against rare and debilitating diseases like cystic fibrosis, patients around the world are benefiting from unprecedented innovation that the biotech industry is delivering. Loncar Funds attributes this innovation to precision medicine. As the … Read more

Progress In Liquid Biopsy Cancer Screening Yields Potential Competition Between China And The U.S.

Progress In Liquid Biopsy Cancer Screening Yields Potential Competition Between China And The U.S.

Two research teams recently reported results from studies involving the long-term evaluation of non-invasive DNA fragments in blood. Evaluating these DNA fragments is called liquid biopsy, and this type of biopsy could vastly improve outcomes through early detection and low false positive rates for a wide variety of cancers. One result is Chinese and the … Read more